These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
429 related articles for article (PubMed ID: 25014746)
41. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling. Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320 [TBL] [Abstract][Full Text] [Related]
42. Synthesis, characterization, DNA binding studies, photocleavage, cytotoxicity and docking studies of ruthenium(II) light switch complexes. Gabra NM; Mustafa B; Kumar YP; Devi CS; Srishailam A; Reddy PV; Reddy KL; Satyanarayana S J Fluoresc; 2014 Jan; 24(1):169-81. PubMed ID: 23982735 [TBL] [Abstract][Full Text] [Related]
43. Organometallic Ru(II), Rh(III) and Re(I) complexes of sterane-based bidentate ligands: synthesis, solution speciation, interaction with biomolecules and anticancer activity. Pivarcsik T; Kiss MA; Rapuš U; Kljun J; Spengler G; Frank É; Turel I; Enyedy ÉA Dalton Trans; 2024 Mar; 53(11):4984-5000. PubMed ID: 38406993 [TBL] [Abstract][Full Text] [Related]
44. Group 9 organometallic compounds for therapeutic and bioanalytical applications. Ma DL; Chan DS; Leung CH Acc Chem Res; 2014 Dec; 47(12):3614-31. PubMed ID: 25369127 [TBL] [Abstract][Full Text] [Related]
45. Synthesis, structural characteristics, DNA binding properties and cytotoxicity studies of a series of Ru(III) complexes. Tan C; Liu J; Chen L; Shi S; Ji L J Inorg Biochem; 2008 Aug; 102(8):1644-53. PubMed ID: 18468690 [TBL] [Abstract][Full Text] [Related]
46. Novel ruthenium complexes ligated with 4-anilinoquinazoline derivatives: synthesis, characterisation and preliminary evaluation of biological activity. Ji L; Zheng W; Lin Y; Wang X; Lü S; Hao X; Luo Q; Li X; Yang L; Wang F Eur J Med Chem; 2014 Apr; 77():110-20. PubMed ID: 24631730 [TBL] [Abstract][Full Text] [Related]
47. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features. Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963 [TBL] [Abstract][Full Text] [Related]
48. Synthesis and biological evaluation of zwitterionic half-sandwich Rhodium(III) and Ruthenium(II) organometallic complexes. Guo L; Hu X; Yang Y; An W; Gao J; Liu Q; Liu Z Bioorg Chem; 2021 Nov; 116():105311. PubMed ID: 34474302 [TBL] [Abstract][Full Text] [Related]
49. Solvent assisted formation of ruthenium(III) and ruthenium(II) hydrazone complexes in one-pot with potential in vitro cytotoxicity and enhanced LDH, NO and ROS release. Jayanthi E; Kalaiselvi S; Padma VV; Bhuvanesh NS; Dharmaraj N Dalton Trans; 2016 Jan; 45(4):1693-707. PubMed ID: 26699435 [TBL] [Abstract][Full Text] [Related]
50. Luminescent cyclometalated iridium(III) polypyridine di-2-picolylamine complexes: synthesis, photophysics, electrochemistry, cation binding, cellular internalization, and cytotoxic activity. Lee PK; Law WH; Liu HW; Lo KK Inorg Chem; 2011 Sep; 50(17):8570-9. PubMed ID: 21834537 [TBL] [Abstract][Full Text] [Related]
51. Ruthenium(II)/(III) complexes of 4-hydroxy-pyridine-2,6-dicarboxylic acid with PPh3/AsPh3 as co-ligand: impact of oxidation state and co-ligands on anticancer activity in vitro. Kamatchi TS; Chitrapriya N; Lee H; Fronczek CF; Fronczek FR; Natarajan K Dalton Trans; 2012 Feb; 41(7):2066-77. PubMed ID: 22183160 [TBL] [Abstract][Full Text] [Related]
52. Role of substitution at terminal nitrogen of 2-oxo-1,2-dihydroquinoline-3-carbaldehyde thiosemicarbazones on the coordination behavior and structure and biological properties of their palladium(II) complexes. Ramachandran E; Senthil Raja D; Rath NP; Natarajan K Inorg Chem; 2013 Feb; 52(3):1504-14. PubMed ID: 23323516 [TBL] [Abstract][Full Text] [Related]
53. Binuclear copper complexes: synthesis, X-ray structure and interaction study with nucleotide/protein by in vitro biochemical and electrochemical analysis. Alagesan M; Bhuvanesh NS; Dharmaraj N Eur J Med Chem; 2014 May; 78():281-93. PubMed ID: 24686015 [TBL] [Abstract][Full Text] [Related]
54. Ru(II)/clotrimazole/diphenylphosphine/bipyridine complexes: Interaction with DNA, BSA and biological potential against tumor cell lines and Mycobacterium tuberculosis. Colina-Vegas L; Dutra JL; Villarreal W; de A Neto JH; Cominetti MR; Pavan F; Navarro M; Batista AA J Inorg Biochem; 2016 Sep; 162():135-145. PubMed ID: 27383651 [TBL] [Abstract][Full Text] [Related]
55. Ruthenium(III) S-methylisothiosemicarbazone Schiff base complexes bearing PPh3/AsPh3 coligand: synthesis, structure and biological investigations, including antioxidant, DNA and protein interaction, and in vitro anticancer activities. Prakash G; Manikandan R; Viswanathamurthi P; Velmurugan K; Nandhakumar R J Photochem Photobiol B; 2014 Sep; 138():63-74. PubMed ID: 24911273 [TBL] [Abstract][Full Text] [Related]
57. Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph₂PCH₂S(O)xPh (x = 0-2) ligands. Ludwig G; Mijatović S; Ranđelović I; Bulatović M; Miljković D; Maksimović-Ivanić D; Korb M; Lang H; Steinborn D; Kaluđerović GN Eur J Med Chem; 2013 Nov; 69():216-22. PubMed ID: 24042044 [TBL] [Abstract][Full Text] [Related]
58. Synthesis, characterization and in vitro pharmacological evaluation of new water soluble Ni(II) complexes of 4N-substituted thiosemicarbazones of 2-oxo-1,2-dihydroquinoline-3-carbaldehyde. Ramachandran E; Senthil Raja D; Bhuvanesh NS; Natarajan K Eur J Med Chem; 2013 Jun; 64():179-89. PubMed ID: 23644201 [TBL] [Abstract][Full Text] [Related]
59. Anomalous behavior of pentacoordinate copper complexes of dimethylphenanthroline and derivatives of terpyridine ligands: Studies on DNA binding, cleavage and apoptotic activity. Rajalakshmi S; Weyhermüller T; Freddy AJ; Vasanthi HR; Nair BU Eur J Med Chem; 2011 Feb; 46(2):608-17. PubMed ID: 21193251 [TBL] [Abstract][Full Text] [Related]